Tomáš Cihlář
virologistMale0.0Global Dominance: 0.00%
Tomáš Cihlář is a Czech virologist and biochemist known for his leadership in the biology department at Gilead Sciences. He has been instrumental in the development of groundbreaking antiviral medications, including Lenacapavir, a newly approved injection for HIV prevention. His work has significantly advanced efforts to combat viral infections, including the development of remdesivir during the COVID-19 pandemic.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Tomáš Cihlář is a Czech virologist and biochemist who leads the biology department at Gilead Sciences and contributed to the development of the drug remdesivir during the COVID-19 pandemic.
Americký úrad schválil injekciu na prevenciu HIVSME – major Slovak daily, est. 1993·
Slovakia· 2025-06-20
Slovakia· 2025-06-20
